Chronic Disease Management Market Research Report - Global Forecast till 2025

Global Chronic Disease Management Market Research Report: By Solution (Educational Solution, Implementation Solution, Consulting Solution and others), Delivery Mode (Cloud-Based, On-Premises and Web-Based), Application (Arthritis, Cardiovascular Disease, Cancer, Diabetes and others), End-User (Providers, Payers) and Region (Americas, Europe, Asia-Pacific, Middle East & Africa) - Forecast till 2025

ID: MRFR/HS/0475-HCR | February 2021 | Region: Global | 90 pages

Market Scenario


Chronic Disease Management Market is projected to reach USD 4000 Million in 2018 and expected to register a 14.5% CAGR during the forecast period. Chronic disease management contains a defined set of interventions mainly aimed at providing high-quality healthcare and a better quality of life to patients. Chronic disease management Solutions include a variety of Solutions, such as guidelines for the self-management of the chronic disease condition, multidisciplinary care, and guidance for a healthy lifestyle, to increase awareness about various diseases.


The primary factors driving the growth of the global chronic disease management market are rising awareness about the seriousness of life-threatening diseases along with rising healthcare expenditure. According to the World Health Organization (WHO), chronic diseases will account for almost three-quarters of all deaths worldwide by 2020 in which 71% of deaths will be due to ischaemic heart disease and 70% of deaths due to diabetes.


However, the non-compliance and lack of adherence among the patients is likely to hamper the global chronic disease Solution market.


Segmentation


The Global Chronic Disease Management Market has been segmented into solution, delivery mode, application, and end user.


By solution, the market has been segmented into educational solution, implementation solution, consulting solution, and others.


 On the application, the market has been segmented into safety arthritis, cardiovascular disease, cancer, diabetes, and others.


Based on delivery mode, the market has been segmented into cloud-based, on-premises, and web-based.


Based on end-user, the market has been segmented into providers, payers, and others.


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Chronic Disease Management market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada.


The European Chronic Disease Management market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The chronic disease management market in Asia-Pacific has been segmented into Japan, China, India, Latin Korea, Australia, and the rest of Asia-Pacific. The Chronic Disease Management market in the Middle East & Africa has been segmented into the Middle East and Africa.


Key Players


TriZetto Corporation (US), Infosys Limited (India), Pegasystems Inc. (US), Siemens Healthcare Private Limited (Germany), MINES & Associates, Inc. (US), Allscripts Healthcare Solutions, Inc. (US), Koninklijke Philips NV (Netherlands), EXL Healthcare (New York), Harmony Information Systems, Inc.(US), ScienceSoft USA Corporation (US) are some of the key players in the global chronic disease management market.


Regional Market Summary


Global Chronic Disease Management Market Share (%), by Region, 2018  Chronic Disease Management Market


Source: Centers for Disease Control and Prevention (CDC), Eurostat, White Papers, Company Presentations, and Annual Reports


Geographically, the market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. It is estimated that Americas dominated the global chronic disease management market owing to the increasing prevalence of chronic disorders, increasing R&D funding for pharma and biotech companies, and increasing healthcare expenditure. For instance, according to the Centres for Disease Control and Prevention, 6 in 10 adults in the US have chronic diseases. Additionally, according to the National Association of Chronic Disease Directors, chronic disease accounts for approximately 75% of the nation's health care spending in the U.S. each year. In terms of public insurance, treatment of chronic disease constitutes an even larger proportion of spending 96 cents per dollar for Medicare and 83 cents per dollar for Medicaid. This huge healthcare expenditure in terms of chronic disorders is driving market growth.


Europe accounted for the second largest in the chronic disease management market owing to the increasing health problems and rising older population. Additionally, rising healthcare expenditure is driving market growth. For instance, according to the National Center for Biotechnology Information, 855 of the deaths in the European Union are due to chronic diseases including cancer, cardiovascular disease, chronic respiratory disease, diabetes, and mental illness. Additionally, healthcare expenditures on cancer in the European Union member states represented 6% of total healthcare expenditures in 2015. 


Additionally, according to the World Health Organization, cancer represents the second most important cause of death and morbidity in Europe. Such high expenditure and rising morbidity due to chronic diseases are driving the growth of the market.


Asia-Pacific was anticipated to be the rapidly growing region for the chronic disease management market. The market is expected to witness growth owing to the increasing population and rising demand for technologically advanced treatments. The prevalence of cancer is high in developing countries and cities, such as Japan, Hong Kong, and India, which support market growth.


The market in the Middle East and Africa holds a low share in the global chronic disease management market due to the presence of a low number of healthcare facilities, low per capita income, and people living in underdeveloped countries are not much aware of the upcoming treatment methods. However, the market is expected to witness growth due to increasing hospitals and rising demand for the products in the Middle East.


Global Chronic Disease Management Market, by Solution



  • Educational Solution

  • Implementation Solution

  • Consulting Solution

  • Others


Global Chronic Disease Management Market, by Delivery Mode  



  • Cloud-Based

  • On-Premises

  • Web-Based


Global Chronic Disease Management Market, by Application



  • Arthritis

  • Cardiovascular Disease

  • Cancer

  • Diabetes

  • Others


Global Chronic Disease Management Market, by End-User



  • Providers

  • Payers

  • Others


Global Chronic Disease Management Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • Latin America





  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe





  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • Latin Korea

    • Rest of Asia-Pacific





  • Middle East & Africa

    • Middle East

    • Africa




Intended Audience



  • Cancer centers

  • Contract Research Organizations (CROs)

  • Research and Development (R&D) Companies

  • Government Research Laboratories

  • Independent Research Laboratories

  • Government and Independent Regulatory Authorities

  • Market Research and Consulting Solution Providers

  • Medical Research Laboratories

  • Academic Medical Institutes and Universities



Frequently Asked Questions (FAQ) :


The global chronic disease management market is expected to register a double-digit CAGR over 14% throughout the assessment period (2019-2025).

The global chronic disease management market had reached USD 4000 MN in 2018.

North America holds the largest share in the global chronic disease management market followed by Europe and Asia Pacific, respectively.

TriZetto Corporation (US), Pegasystems Inc. (US), Infosys Limited (India), Siemens Healthcare Private Limited (Germany), Allscripts Healthcare Solutions, Inc. (US), MINES & Associates, Inc. (US), Koninklijke Philips NV (Netherlands), Harmony Information Systems, Inc.(US), EXL Healthcare (New York), and ScienceSoft USA Corporation (US), are some of the major players operating in the global chronic disease management market.